What's New
Special Offers
LabLINK Newsletter
Molecular Biology Product Directory
Controlled Pore Glass Products
More Info/Tech Questions
Ordering Info
Search PureBiotech
About PureBiotech
Home
PureBiotech, LLC - LabLINK

Index: Volume 4 Number 1
Next Article: 3' Biotin End Labeling, made easy

 

Improved mRNA Isolation Goto Product in Catalog

By Anthony J. Salerno, Ph.D., PureBiotech LLC

Introduction

A rapid method for the purification of high quality mRNA has been further optimized for speed and ease. This new method has been incorporated into PureBiotech LLC's solid phase affinity purification based "mRNA direct" kits which are noted for the ease and speed with which high quality mRNA can be prepared. PureBiotech, LLC's kits employ streptavidin coated magnetic porous glass (MPGŪ) as the solid phase combined with an oligo (dT)25 probe to isolate mRNA from either tissue, cells or total RNA. As shown in the report the ease and speed of these kits has been optimized while maintaining the high yield and purities of the resultant mRNA. This was accomplished by the inclusion of a prebound probe to the MPGŪ Streptavidin. Previously, the user needed to bind the probe to MPGŪ Streptavidin prior to the RNA isolation step. The PureBiotech LLC kits which incorporate this new improved prebound system are; MPGŪ Direct mRNA Purification Kit (MDRK), MPGŪ Guanidine Direct mRNA Purification Kit (MGRK), MPGŪ mRNA Purification Kit (MRRK), and SOLIDscript(tm) Solid Phase cDNA Synthesis Kit (SSP).

Speed & Ease

A study was done comparing the completed protocol times of the original mRNA kits to the newly optimized version. By including the new prebound MPGŪ Streptavidin-Oligo (dT)25 Complex and eliminating the binding and washing steps from the protocol a significant time savings was achieved. Table 1 below illustrates that the new completion time has been reduced by 25% in most instances.

Table 1: Time Comparison of Old Kit Format vs. New Kit Format

mRNA Isolation Time cDNA Generation Time
Kit Format MDRK MGRK MRRK SSP
Original <20 min. <20 min. <20 min. <110 min.
Improved <15 min. <15 min. <15 min. <104 min.

Optimized parameters for easy mRNA isolation

In addition to improving the speed and ease of the kits, we focused on optimizing the conditions of the isolation. The first step was the optimization of the loading of biotinylated oligo (dT)25 to provide the highest mRNA yields from the new MPGŪ Streptavidin -oligo (dT)25 complex. The MPGŪ Streptavidin particles are independently quality control tested to meet a standard of at least 1500 pmol free biotin binding/mg of particles. High yields of mRNA are obtained over a fairly wide range of oligo (dT)25 loadings as shown in the histogram in Figure 1. It is apparent that loadings in excess of 800 pmol oligo (dT)25/mg MPGŪ result in little additional mRNA recovered. Therefore, the new kit format employs an optimal loading of 800 pmol oligo (dT)25/mg MPGŪ Streptavidin for maximal yield of mRNA.

Figure 1: mRNA yeild as a function of oligo(dT)25 loading
Using the PureBiotech LLC MDRK Kit the yield of mRNA recovered from 0.1 g of mouse liver was assayed spectrophotometrically. One mg MPGŪ Streptavidin and the indicated loadings of biotinylated oligo(dT)25 were used.

Time Course for mRNA Binding to the MPGŪ Streptavidin- Oligo (dT)25 Complex

The length of time for complete binding was studied. Figure 2 shows the annealing kinetics for various samples. For all samples, the specific binding of polyadenylated mRNA to the MPGŪ Streptavidin-Oligo(dT)25 Complex was completed within 5 minutes. After 5 minutes, the majority of additional binding experienced is non-specific. As shown in Table 2, this weak non-specific binding of mRNA to the complex is easily removed in the subsequent washing steps. Table 2 also shows the amount of mRNA recovered after washing away impurities and loosely bound mRNA. This represents the maximum binding capacity or yield per mg MPGŪ Streptavidin- Oligo (dT)25 Complex. The lower binding capacity for globin compared to mouse liver RNA is consistent with the small size of globin mRNA [a and b < 600 bases1,2] relative to the length of the majority of mRNA present in mouse liver3.


Figure 2: Binding Kinetics of Streptavidin-Oligo (dT)25 Complex
Rabbit globin RNA was 3' end-labeled with a-[32P] cordycepin triphosphate using yeast poly A polymerase and unincorporated label removed on a PureBiotech LLC SPIN-Pure™ Column (SCT25-50 ) followed by ethanol precipitation. The globin was mixed with mouse liver total RNA or mouse liver homogenate and used as a tracer to follow the binding and release of mRNA during purification using the MRRK and MGRK kit protocols, respectively. An excess of mRNA was used for each sample; 5 µg/0.4 ml for globin mRNA, 250 µg/0.7 ml for total RNA, and 1.5 ml of a 1/33 total dilution of mouse liver (homogenate). For the liver samples the globin tracer represented about 5% of the total mRNA present. MPGŪ Streptavidin with no bound oligo (dT)25 was used as a control to examine the nonspecific binding properties of mRNA. At various times, RNA samples were taken, mixed with MPGŪ Streptavidin, magnetically separated and the supernatant removed. The radioactivity remaining in the supernatant was assayed.

Table 2: Specific Binding Capacity per mg MPGŪ Streptavidin- Oligo (dT)25 Complex

  mRNA (µg)
Sample Bound Recovered Retained on MPGŪ
Globin alone 5.3 4.1 < 0.1
Globin + Mouse liver total RNA 10.6a 6.6 < 0.1a
Globin + Mouse liver MGRK homogenate 20.6a 6.3 < 0.1a
Globin alone without oligo (dT) 0.7 < 0.1 < 0.1
Globin + Mouse liver total RNA without oligo (dT) 1.4ab < 0.1 < 0.1ab
Globin + Mouse liver MGRK homogenate without oligo (dT) 8.9ac < 0.1 < 0.1ac
aCalculated using the specific activity determined for the recovered mRNA.
bCalculated using the specific activity for mouse liver total RNA.
cCalculated using the specific activity for mouse liver MGRK Homogenate.

Shelf life of MPGŪ Streptavidin- Oligo (dT)25 Complex

Further studies were done to determine the shelf life of the new complex. The testing showed that the MPGŪ Streptavidin- Oligo (dT)25 Complex remains stable for at least one year when stored in the supplied buffer at 4¡C (Figure 3).


Figure 3. Storage Stability of MPGŪ Streptavidin-Oligo(dT)25 Complex.
On day 0 the MPGŪ Streptavidin- Oligo(dT)25 complex was prepared and assayed for mRNA binding capacity using excess mouse liver homogenate or total RNA. The complex was stored at 4°C in storage buffer and at the times indicated the complex was reassayed and compared to the binding capacity of freshly prepared complex using the same lot of MPGŪ Streptavidin.

Purity of mRNA

Purity testing was done to confirm that the new complex yielded superior quality mRNA. Figure 4 compares the purity of mRNA isolated from a common total RNA sample using market leading cellulose and polystyrene based solid phase kits with PureBiotech, LLC's MPGŪ mRNA Purification Kit. Each solid phase was used according to the supplier's recommended protocol. The MPGŪ based kit yielded the purest mRNA. The others show substantial 18S rRNA contamination. This result reflects the highly effective and very time efficient washing achievable with MPGŪ.

Figure 4. Purity comparison of mRNA isolated using market leading solid phase purification kits.
Total RNA was prepared from mouse liver using PureBiotech, LLC's Total RNA Isolation Kit (MTRK). Messenger RNA was prepared from this RNA using the leading oligo (dT)- cellulose/spin basket based kit (lanes 1 and 2), the leading oligo (dT) polystyrene-latex/spin basket based kit (lanes 3 and 4), or PureBiotech, LLC's MPG mRNA Purification Kit (MRRK) (lanes 5 and 6). Each solid phase was used according to the supplier's recommended protocol. Samples (1 µg) of the non retained RNA (lanes 1,3, and 5) and purified mRNA (lanes 2,4 and 6)were electrophoresed on a 1% formaldehyde/agarose gel and a Northern blot was performed. The blot was hybridized to a 32P-labeled probe specific for 18S ribosomal RNA.

Versatility and Convenience

The use of MPGŪ magnetic particle technology for direct mRNA isolation provides mRNA of high quality, yield, and purity now in an industry leading short time of 15 minutes or less. There is no longer any need for cumbersome manipulations. The purified mRNA can be eluted off the MPGŪ in any convenient volume of low salt elution buffer. The protocol is also readily adapted to microtiter plates for high throughput sample processing on robotic workstations.

  1. Heindell, H.C., Liu, A., Paddock, G.V., Studnicka, G.M. and Salser, W.A. (1978) Cell 15(1), 43.
  2. Kafatos, F.C., Efstratiadis, A., Forget, B.G. and Weissman, S.M. (1977) Proc. Natl. Acad. Sci. U.S.A. 74(12), 5618.
  3. Sambrook, J., Fritsch, E.F., and Maniatis, T. Molecular Cloning: A Laboratory Manual (1989) Cold Spring Harbor Laboratory Press, vol. 1, p 7.51.

Next Article: 3' Biotin End Labeling, made easy...

 

 

© 2004-2023 PureBiotech LLC All rights reserved.